The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Rating of "Moderate Buy" from Brokerages

Key Points

• Seventeen analysts give Cooper Companies an average recommendation of "Moderate Buy" (1 sell, 7 hold, 8 buy, 1 strong buy) with an average 1‑year price target of $90.79.
• Cooper reported Q earnings of $1.10 EPS versus $1.03 expected and revenue of $1.02B (up 6.2% YoY), and set Q2 2026 guidance of 4.580–4.660 EPS (analysts forecast ~4.62).
• Shares opened at $63.09 (down 1.9%), trading near their 1‑year low of $61.78 versus a high of $89.83; the company has a $12.31B market cap and a P/E of 31.23.

Shares of The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seventeen analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $90.7857.

COO has been the topic of several recent analyst reports. Weiss Ratings raised Cooper Companies from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Monday, January 12th. Citigroup cut their target price on Cooper Companies from $88.00 to $87.00 and set a "neutral" rating on the stock in a research note on Friday, March 6th. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a research note on Saturday, February 28th. Barclays boosted their price objective on Cooper Companies from $98.00 to $103.00 and gave the stock an "overweight" rating in a research note on Friday, March 6th. Finally, Rothschild & Co Redburn downgraded Cooper Companies from a "buy" rating to a "neutral" rating and set a $85.00 price objective on the stock. in a research note on Wednesday, March 4th.

Cooper Companies Stock Down 1.9%

Shares of Cooper Companies stock opened at $63.09 on Wednesday. The business's fifty day moving average price is $73.38 and its two-hundred day moving average price is $76.40. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a market capitalization of $12.31 billion, a P/E ratio of 31.23, a PEG ratio of 1.66 and a beta of 1.07. Cooper Companies has a 1-year low of $61.78 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, research analysts forecast that Cooper Companies will post 4.62 EPS for the current year.

Institutional Trading of Cooper Companies

A number of hedge funds and other institutional investors have recently modified their holdings of COO. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company's stock worth $2,241,000 after acquiring an additional 158 shares during the last quarter. Root Financial Partners LLC grew its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after acquiring an additional 162 shares during the last quarter. Allworth Financial LP grew its holdings in shares of Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company's stock worth $111,000 after acquiring an additional 167 shares during the last quarter. Mesirow Financial Investment Management Inc. grew its holdings in shares of Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company's stock worth $961,000 after acquiring an additional 175 shares during the last quarter. Finally, Pacer Advisors Inc. grew its holdings in shares of Cooper Companies by 0.8% in the 3rd quarter. Pacer Advisors Inc. now owns 23,079 shares of the medical device company's stock worth $1,582,000 after acquiring an additional 182 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.